European Cardiology Review endeavours to publish unbiased content pertinent to cardiologists. All articles submitted must be of an impartial nature.
The title and scope of articles should be agreed with the Editor-in-Chief and Managing Editor prior to submission. Uninvited submissions will be considered provided they meet our publication criteria.
If you are interested in submitting a manuscript, please contact the Managing Editor if you have a pre-submisison enquiry or submit a paper directly here. Following submission, articles will be subject to independent double-blind peer review and in-house editing prior to publication. All articles must receive the approval of the Editor-in-Chief before publication.
All editorial queries should be directed to the Managing Editor: firstname.lastname@example.org.
The following article types appear in European Cardiology Review:
- Guest Editorial – Approximately 800 words in length (excluding references)
- Review Article – Approximately 3,000 words in length (excluding references)
- Viewpoint Article – Approximately 1,500 words in length (excluding references)
- Systematic Review – Approximately 4,000 words in length (excluding references)
All manuscripts must be supplied in Microsoft Word.
All submissions must include:
- A Title Page – Comprising: the title of the article; short title (< 50 characters); author(s)’ full name, position and institution; a statement of disclosure/conflicts of interest relevant to the article for each author (conversely, please state clearly if there are no conflicts of interest to declare); a postal correspondence address for the lead author; email addresses for all authors
- A Supporting Information Page – Comprising: a short biography of each author for inclusion on the journal website; a brief summary of the paper (two to three sentences) and an image (.jpeg format) to accompany the article title on the electronic table of contents
Expert Opinion and Review Articles must also include:
- An unstructured, unreferenced abstract (approximately 120 words).
- A list of keywords (5–12 words).
Layout: Divide the text under headings and subheadings. Keep these short and succinct and similar in sense and style.
Language: All articles should be written in plain, UK English, free from jargon, and the writing should be clear and direct. All acronyms and abbreviations must be explained in full at first mention.
Figures – Tables, illustrations, screenshots and photographs:
- A maximum of five may be included.
- Clear and concise titles/captions must be provided, and all symbols and abbreviations used must be defined in a footnote.
- All figures must be referred to in the main text.
- Figures must be supplied as digital files only (.tif, .pdf or .jpeg files) and be at least 300 dpi.
- Graphs and tables must be supplied as editable files formatted as a table in Microsoft Word or Excel.
- Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Evidence will need to be provided where permission has been granted upon request.
- In text – All articles must be fully referenced using the Vancouver in-text referencing style. References must be numbered in order of first mention. They must be indicated in the text by a superscript number with the full list at the end of the article in numerical order.
- Reference list – Journal abbreviations are used as per Medline. Include the first three authors only.
- Example references:
- Journal article – Delpón E, Cordeiro JM, Núñez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008; 1: 209–18. https://doi.org/10.1161/CIRCEP.107.748103; PMID: 19122847.
- Book Chapter – H Mansbach, Sumatriptan: Looking Back and Looking Forward. In: Humphrey P, Ferari M and Olesen J (eds ), The Triptans: Novel Drugs for Migraine, New York: Oxford University Press, 2001;183–9.
Author Disclosures – Authors must disclose any conflicts of interest pertaining to the article. This includes any commercial interests that may be construed to have influenced opinion such as research funding, consultancy services, serving on speakers’ bureaus, travel expenses, appearance fees, the receipt of share options, or direct employment by a commercial entity. Conversely, please state clearly should there be no conflicts of interest to declare.
For more information and to download a Form for Disclosure of Potential Conflicts of Interest, which should be submitted with your manuscript, please visit: www.icmje.org/conflicts-of-interest
Acknowledgements – The author(s) should acknowledge substantive contributions to the article, including receipt of financial assistance, materials and other resources.
Informed Consent – Authors should include a statement in the manuscript that informed consent was obtained, if experimentation with human subjects was conducted. The privacy rights of human subjects must always be observed. For more information please read: http://www.radcliffecardiology.com/privacy-statement.
The journal’s human and animal rights policy can be viewed here.
Articles that do not fall within the aims and scope of the journal will be rejected outright.
Articles submitted that fall within the aims and scope of the journal will be subjected to independent double-blind peer review. Peer reviewers are selected on the basis of their expertise in the article subject matter. Following review, manuscripts are accepted without modification, accepted pending modification (in which case the manuscripts are returned to the author/s to incorporate required changes), or rejected. The Editor-in-Chief reserves the right to accept or reject any proposed amendments. Once the authors have revised a manuscript in accordance with the reviewers’ comments, the manuscript is assessed to ensure the revised version meets quality expectations. The Editor-in-Chief provides final approval for acceptance for publication. Copyright for the publication and reproduction of submitted articles transfers to Radcliffe Cardiology.
Open Access, Copyright and Permission
Articles published within this journal are open access, which allows users to copy, redistribute and make derivative works for non-commerical purposes, provided the original work is cited correctly. The author retains all non-commerical rights for articles published under the CC-BY-NC 4.0 license.
Radcliffe Cardiology retains all commerical rights for articles herein unless otherwise stated. Permission to reproduce an article or any of its contents for commerical purposes, either in full or in part, should be sought from the publication's Managing Editor.
Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Evidence will need to be provided where permission has been granted upon request.
To support open access publication costs, Radcliffe Cardiology charge an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper as follows: £1,050 UK | €1,200 Eurozone | $1,369 all other countries.
(Submissions from the UK will be subject to the current UK VAT charge. A VAT registration number should be supplied to ensure any invoice accounts for VAT at your local relevant rate. Those not registered for VAT will have VAT added.)
APC Waivers and Discounts
A 100% waiver is available for all papers which are solicited directly from Radcliffe Cardiology.
Authors from low-income countries as defined by the World Bank are eligible for a full waiver of the APC charge. Authors from middle-income countries are eligible for a 50% waiver. Discretionary waivers may also be considered.
Radcliffe Cardiology remains dedicated to helping researchers to disseminate scientific information globally and is actively working to partner with individual institutions to offer full or partial APC discounts. Institutional agreements will be listed here. If you are an institution looking to partner with us, or think your institution should, then please contact the Publishing Director.
To ensure editorial integrity, the waiver process is not handled by the journal Managing Editors. Authors should submit a waiver request during the electronic submission process.
All accepted manuscripts will be subject to editorial revisions for clarity, punctuation, syntax and conformity to house style. Wherever possible, the author/s will be fully involved in the editorial process, although the final decision remains with the publisher.
A PDF proof of manuscripts accepted for publication will be sent to the corresponding author. Any requests for changes must be returned by the deadline given. Only minor changes can be made at the proofing stage. It is the corresponding author’s responsibility to liaise with co-authors on any needed corrections or proof approval.
Errors and Omissions
Radcliffe Cardiology takes care to ensure that all content is reproduced correctly; however, due to human or mechanical errors, we cannot guarantee the accuracy, adequacy or completeness of any information and cannot be held responsible for any errors or omissions, or for the results obtained from the use thereof.
Reprints of all published articles are available to authors, institutions and commercial organisations.
Please contact email@example.com.
All editorial queries should be directed to firstname.lastname@example.org.
Click here to download these guidelines as a PDF.